/REZN.CN

REZN.CN Stock - The Hash Corporation

Q: What is the analyst price target for REZN.CN?

Analyst price target information is not currently available for REZN.CN.

Q: What is REZN.CN's market cap?

Market capitalization information is not currently available for REZN.CN.

Healthcare|Drug Manufacturers - Specialty & Generic|CNQ

$0.01+0.00%

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for REZN.CN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.81

52W High$0.01

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$553,956	$805,600	$892,393	N/A	N/A
Gross Profit	$317,734	$382,031	$273,945	$-18,682	N/A
Gross Margin	57.4%	47.4%	30.7%	N/A	N/A
Operating Income	$-265,861	$-1,356,440	$-4,633,023	$-2,021,138	$-2,041,096
Net Income	$-419,981	$-1,461,568	$-4,641,917	$-2,021,138	$-2,041,096
Net Margin	-75.8%	-181.4%	-520.2%	N/A	N/A
EPS	$-0.00	$-0.01	$-0.02	$-0.01	$-0.01

Company Overview

The Hash Corporation focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada. The company was formerly known as Senternet Phi Gamma Inc. and changed its name to The Hash Corporation in July 2019. The Hash Corporation was incorporated in 1967 and is headquartered in Toronto, Canada.

Visit Website

Earnings History & Surprises

REZN.CN

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q3 2023

EPS Surprise History

Q1 23

No data

Q2 23

No data

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$-0.00	—	—
Q2 2023	Jun 30, 2023	—	$-0.00	—	—
Q1 2023	Mar 31, 2023	—	$-0.00	—	—

Frequently Asked Questions about REZN.CN

What is REZN.CN's current stock price?

The Hash Corporation (REZN.CN) is currently trading at $0.01 per share. The stock has moved +0.00% today.

What is the analyst price target for REZN.CN?

No analyst price targets are currently available for this stock.

What sector is The Hash Corporation in?

The Hash Corporation operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.

What is REZN.CN's market cap?

The Hash Corporation has a market capitalization of $0.00 billion, making it a small-cap company.

Does REZN.CN pay dividends?

No, The Hash Corporation does not currently pay a dividend to shareholders.